Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling.

Saved in:

Bibliographic Details
Title:	Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling.
Authors:	Farrell M; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States.; Tufts University School of Medicine, Boston, United States., Fairfield H; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States.; Tufts University School of Medicine, Boston, United States., Karam M; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States., D'Amico A; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States., Murphy CS; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States., Falank C; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States., Pistofidi RS; Dana-Farber Cancer Institute, Boston, United States.; Harvard Medical School, Boston, United States., Cao A; Dana-Farber Cancer Institute, Boston, United States.; Harvard Medical School, Boston, United States., Marinac CR; Dana-Farber Cancer Institute, Boston, United States.; Harvard Medical School, Boston, United States., Dragon JA; University of Vermont, Burlington, United States., McGuinness L; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; University of New England, Biddeford, United States., Gartner CG; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States.; Tufts University School of Medicine, Boston, United States., Iorio RD; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; University of New England, Biddeford, United States., Jachimowicz E; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States., DeMambro V; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States., Vary C; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States.; Tufts University School of Medicine, Boston, United States., Reagan MR; Center for Molecular Medicine, Maine Health Institute for Research, Scarborough, United States.; Graduate School of Biomedical Science and Engineering, University of Maine, Orono, United States.; Tufts University School of Medicine, Boston, United States.
Source:	ELife [Elife] 2023 Mar 07; Vol. 12. Date of Electronic Publication: 2023 Mar 07.
Publication Type:	Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2050-084X
DOI:	10.7554/eLife.81184